Psychiatric News (7/19) reports, “Patients with schizophrenia may be less likely to stop treatment if prescribed clozapine or the long-acting injectable (LAI) formulations of aripiprazole and paliperidone compared with oral olanzapine,” investigators concluded in a study that “made use of data from over 37,000 veterans.” The findings were published online July 14 in the American Journal of Psychiatry, a publication of the American Psychiatric Association.

Related Links:

— “VA Study Shows Patients With Schizophrenia Least Likely to Discontinue Clozapine, LAI Antipsychotics, Psychiatric News, July 19, 2021

Healio (7/19, Gramigna) reports, “Individuals with mental disorders, particularly those with schizophrenia, received less screening and lower-quality treatment for cardiovascular disease,” investigators concluded in a systematic review and meta-analysis that “included 47 studies with a total of 24,400,452 individuals, of whom 1,283,602 had mental disorders.” The findings were published online July 14 in the American Journal of Psychiatry, a publication of the American Psychiatric Association.

Related Links:

— “Individuals With Mental Disorders May Receive Less Screening, Lower-Quality Treatment For Cardiovascular Disease, Systematic Review Suggests “Joe Gramigna, Healio, July 19, 2021

Healio (7/15, Schaffer) reported, “Adults with diabetes and depression who take antidepressant medications as prescribed are less likely to develop serious diabetes complications or die compared with those not taking antidepressants regularly,” investigators concluded in a retrospective study that “analyzed data from 36,276 adults with depression and newly treated diabetes, using Taiwan’s universal health insurance database.” The findings were published online in the Journal of Clinical Endocrinology & Metabolism.

Related Links:

— “Regular antidepressant use may lower risk for advanced diabetes complications “Regina Schaffer, Healio, July 15, 2021

Healio (7/16, Gramigna) reported, “One-fourth of people at clinical high risk for psychosis developed psychosis within three years,” investigators concluded in “an updated meta-analysis” that “included 130 longitudinal studies that reported transition risks among a total of 9,222 individuals at clinical high risk for psychosis (mean age, 20.3 years; 55.3% men).” The findings were published online July 14 in JAMA Psychiatry.
“ Risk of transitioning to psychosis was higher in studies with a lower proportion of female individuals and a higher proportion of individuals presenting with brief limited intermittent psychotic symptoms.
Meaning This updated meta-analysis indicates that the probability of transitioning to psychosis in individuals at clinical high risk is substantial and continues increasing in the long term, suggesting that an extended duration of clinical monitoring and preventive care may be beneficial.”

Related Links:

— “25% of people at clinical high risk for psychosis develop the disorder within 3 years “Joe Gramigna, Healio, July 16, 2021

The Washington Post (7/16, Sibboney) reported, “Already subject to unique discrimination at the intersection of gender and race, Black girls with” attention-deficit/hyperactivity disorder (AD/HD) “often remain undiagnosed because their symptoms are mischaracterized.” Signs of “inattentiveness or impulsivity, the two main features of the disorder, could be mistaken for laziness or defiance.” What’s more, “the longer these girls aren’t diagnosed and treated, the more their problems are likely to worsen as they grow into adults.”

Related Links:

— “The Washington Post (requires login and subscription)